<DOC>
	<DOCNO>NCT00643734</DOCNO>
	<brief_summary>The study perform see single , 2.0-g oral dose azithromycin sustain release ( SR ) least effective 7-day regimen levofloxacin ( 500 mg daily ) treatment mild moderate community-acquired pneumonia , assess efficacy safety treatment regimen .</brief_summary>
	<brief_title>A Multicenter , Randomized , Double-Blind , Double-Dummy Trial Azithromycin SR Compared With Levofloxacin Treatment Mild Moderate Pneumonia Adult Patients</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Patients clinical evidence mild moderate communityacquired pneumonia , include cough productive sputum diagnosis pneumonia , include . Key exclusion criterion treatment systemic antibiotic great one dose one combination dose within previous 7 day , previously diagnose condition tend mimic complicate course evaluation evaluation process ( e.g. , bronchiectasis , lung abscess empyema , active tuberculosis , pulmonary malignancy , cystic fibrosis , postobstructive pneumonia ) , hospitalization previous 14 day infection acquire hospital , resident longterm care facility .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>